{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:53:05Z","timestamp":1772776385621,"version":"3.50.1"},"reference-count":22,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>La histiocitosis de c\u00e9lulas de Langerhans es una enfermedad poco frecuente, cuyas manifestaciones cl\u00ednicas pueden aparecer en el periodo neonatal y var\u00edan desde lesiones \u00f3seas aisladas hasta un compromiso sist\u00e9mico.Se describe un caso de histiocitosis de c\u00e9lulas de Langerhans y se revisa la literatura m\u00e9dica sobre las manifestaciones cl\u00ednicas, el diagn\u00f3stico y el tratamiento. El paciente de un mes de nacido fue llevado a consulta por presentar adenopat\u00edas y lesiones en la piel que, inicialmente, fueron tratadas como reacci\u00f3n a una infecci\u00f3n. La enfermedad continu\u00f3 su progresi\u00f3n sin que hubiera mejor\u00eda con el tratamiento, hasta que el paciente falleci\u00f3 por falla respiratoria.La biopsia de ganglio linf\u00e1tico y la de piel revelaron infiltraci\u00f3n de c\u00e9lulas at\u00edpicas, y la inmunohistoqu\u00edmica result\u00f3 positiva para las prote\u00ednas S100, CD1 y CD68, con lo cual se confirm\u00f3 el diagn\u00f3stico de histiocitosis de c\u00e9lulas de Langerhans.Esta alteraci\u00f3n representa un gran desaf\u00edo cl\u00ednico, por lo que es importante alertar y sensibilizar al equipo m\u00e9dico para lograr un diagn\u00f3stico y un tratamiento m\u00e1s oportunos.<\/jats:p>","DOI":"10.7705\/biomedica.5150","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T19:26:44Z","timestamp":1601321204000},"page":"464-471","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":6,"title":["Histiocitosis cong\u00e9nita de c\u00e9lulas de Langerhans"],"prefix":"10.7705","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7426-1831","authenticated-orcid":false,"given":"Katherine","family":"Barrios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-4137","authenticated-orcid":false,"given":"Oscar","family":"Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-7302","authenticated-orcid":false,"given":"Nelson","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-8049","authenticated-orcid":false,"given":"Carlos","family":"Moneriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"99690","doi-asserted-by":"crossref","unstructured":"Morimoto A, Oh Y, Shioda Y, Kudo K, Imamura T. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014;56:451-61. https:\/\/doi.org\/10.1111\/ped.12380","DOI":"10.1111\/ped.12380"},{"key":"99691","doi-asserted-by":"crossref","unstructured":"Filipovich A, McClain K, Grom A. Histiocytic disorders: Recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16(Suppl.):S82-9. https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.014","DOI":"10.1016\/j.bbmt.2009.11.014"},{"key":"99692","doi-asserted-by":"crossref","unstructured":"Jaffe R. The diagnostic histopathology of Langerhans cell histiocytosis. In: Egeler RM, Weitzman S, editors. Histiocytic disorders of children and adults: Basic science, clinical features and therapy. Cambridge: Cambridge University Press; 2005. p. 14-39. https:\/\/doi.org\/10.1017\/CBO9780511545252.003","DOI":"10.1017\/CBO9780511545252.003"},{"key":"99693","doi-asserted-by":"crossref","unstructured":"Jezierska M, Stefanowicz J, Romanowicz G, Kosiak W, Lange M. Langerhans cell histiocytosis in children - a disease with many faces. Recent advances in pathogenesis, diagnostic examinations and treatment. Postepy Dermatol Alergol. 2018;35:6-17. https:\/\/doi.org\/10.5114\/pdia.2017.67095","DOI":"10.5114\/pdia.2017.67095"},{"key":"99694","doi-asserted-by":"crossref","unstructured":"Abla O, Egeler RM, Weitzman S. Langerhans cell histiocytosis: Current concepts and treatments. Cancer Treat Rev. 2010;36:354-9. https:\/\/doi.org\/10.1016\/j.ctrv.2010.02.012","DOI":"10.1016\/j.ctrv.2010.02.012"},{"key":"99695","doi-asserted-by":"crossref","unstructured":"Grana N. Langerhans cell histiocytosis. Cancer Control. 2014;21:328-34. https:\/\/doi.org\/10.1177\/107327481402100409","DOI":"10.1177\/107327481402100409"},{"key":"99696","doi-asserted-by":"crossref","unstructured":"Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn R, Windebank KP. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child. 2009;94:376-80. https:\/\/doi.org\/10.1136\/adc.2008.144527","DOI":"10.1136\/adc.2008.144527"},{"key":"99697","doi-asserted-by":"crossref","unstructured":"Castro EC, Bl\u00e1zquez C, Boyd J, Correa H, de Chadarevian JP, Felgar RE, et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010;13:225-37. https:\/\/doi.org\/10.2350\/09-03-0622-OA.1","DOI":"10.2350\/09-03-0622-OA.1"},{"key":"99698","doi-asserted-by":"crossref","unstructured":"Krooks J, Minkov M, Weatherall AG. Langerhans cell histiocytosis in children: Diagnosis, differential diagnosis, treatment, sequelae, and standardized follow-up. J Am Acad Dermatol. 2018;78:1047-56. https:\/\/doi.org\/10.1016\/j.jaad.2017.05.060","DOI":"10.1016\/j.jaad.2017.05.060"},{"key":"99699","doi-asserted-by":"crossref","unstructured":"Frade AP, Godinho MM, Batalha AB, Bueno APS. Congenital Langerhans cell histiocytosis: A good prognosis disease? An Bras Dermatol. 2017;92:40-2. https:\/\/doi.org\/10.1590\/abd1806-4841.20175308","DOI":"10.1590\/abd1806-4841.20175308"},{"key":"99700","doi-asserted-by":"crossref","unstructured":"Grois N, P\u00f6tschger U, Prosch H, Minkov M, Arico M, Braier J, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46:228-33. https:\/\/doi.org\/10.1002\/pbc.20425","DOI":"10.1002\/pbc.20425"},{"key":"99701","doi-asserted-by":"crossref","unstructured":"Merglova V, Hrusak D, Boudova L, Mukensnabl P, Valentova E, Hosticka L. Langerhans cell histiocytosis in childhood - review, symptoms in the oral cavity, differential diagnosis and report of two cases. J Craniomaxillofac Surg. 2014;42:93-100. https:\/\/doi.org\/10.1016\/j.jcms.2013.03.005","DOI":"10.1016\/j.jcms.2013.03.005"},{"key":"99702","doi-asserted-by":"crossref","unstructured":"Krooks J, Minkov M, Weatherall AG. Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis. J Am Acad Dermatol. 2018;78:1035-44. https:\/\/doi.org\/10.1016\/j.jaad.2017.05.059","DOI":"10.1016\/j.jaad.2017.05.059"},{"key":"99703","doi-asserted-by":"crossref","unstructured":"Kapur P, Erickson C, Rakheja D, Carder KR, Hoang MP. Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): Ten-year experience at Dallas Children\u2019s Medical Center. J Am Acad Dermatol. 2007;56:290-4. https:\/\/doi.org\/10.1016\/j.jaad.2006.09.001","DOI":"10.1016\/j.jaad.2006.09.001"},{"key":"99704","doi-asserted-by":"crossref","unstructured":"Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: Back to histiocytosis X? Br J Haematol. 2015;169:3-13. https:\/\/doi.org\/10.1111\/bjh.13247","DOI":"10.1111\/bjh.13247"},{"key":"99705","doi-asserted-by":"crossref","unstructured":"Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:72-80. https:\/\/doi.org\/10.1002\/mpo.2950230203","DOI":"10.1002\/mpo.2950230203"},{"key":"99706","doi-asserted-by":"crossref","unstructured":"Hutter C, Minkov M. Insights into the pathogenesis of Langerhans cell histiocytosis: The development of targeted therapies. Immunotargets Ther. 2016;5:81-91. https:\/\/doi.org\/10.2147\/ITT.S91058","DOI":"10.2147\/ITT.S91058"},{"key":"99707","doi-asserted-by":"crossref","unstructured":"Nakajima K, Morisawa R, Kodama H, Sano S. Successful treatment with cyclophosphamide of Langerhans cell histiocytosis involving the skin and lymph nodes in an adult patient. Clin Exp Dermatol. 2010;35:791-2. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03802.x","DOI":"10.1111\/j.1365-2230.2010.03802.x"},{"key":"99708","doi-asserted-by":"crossref","unstructured":"Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, et al. A randomized trial of treatment for multisystem Langerhans cell histiocytosis. J Pediatr. 2001;138:728-34. https:\/\/doi.org\/10.1067\/mpd.2001.111331","DOI":"10.1067\/mpd.2001.111331"},{"key":"99709","doi-asserted-by":"crossref","unstructured":"Morimoto A, Ikushima S, Kinugawa N, Ishii E, Kohdera U, Sako M, et al. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis. Cancer. 2006;107:613-9. https:\/\/doi.org\/10.1002\/cncr.21985","DOI":"10.1002\/cncr.21985"},{"key":"99710","doi-asserted-by":"crossref","unstructured":"Ronceray L, P\u00f6tschger U, Janka G, Gadner H, Minkov M. Pulmonary involvement in pediatric-onset multisystem langerhans cell histiocytosis: Effect on course and outcome. J Pediatr. 2012;161:129-33.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2011.12.035","DOI":"10.1016\/j.jpeds.2011.12.035"},{"key":"99711","doi-asserted-by":"crossref","unstructured":"Gadner H, Minkov M, Grois N, P\u00f6tschger U, Thiem E, Aric\u00f2 M, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121:5006-14. https:\/\/doi.org\/10.1182\/blood-2012-09-455774","DOI":"10.1182\/blood-2012-09-455774"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5150\/4555","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5150\/4555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:47:32Z","timestamp":1602182852000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,24]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5150","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"2020-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Case presentation","name":"content_type","label":"Content Type"}]}}